Matrix metalloproteinase-9 expression in the nuclear compartment of neurons and glial cells in aging and stroke

Neuropathology

Volumn 32, Issue 5, 2012, Pages 492-504

  Pirici, Daniel ^a,c   Pirici, Ionica ^a   Mogoanta, Laurentiu ^a   Margaritescu, Otilia ^b   Tudorica, Valerica ^a   Margaritescu, Claudiu ^a   Ion, Daniela A ^c   Simionescu, Cristiana ^a   Coconu, Marieta ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b Clinical Emergency County Hospital No1   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Aging; Glial cells; Neurons; Nuclear MMP 9; Stroke

Indexed keywords

CASPASE 3; GELATINASE B;

ADULT; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CELL AGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NERVE CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STROKE PATIENT;

ADULT; AGED; AGED, 80 AND OVER; AGING; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOOD VESSELS; CASPASE 3; CELL MEMBRANE; CELL NUCLEUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEUROGLIA; NEURONS; PARAFFIN EMBEDDING; STROKE; TISSUE FIXATION;

EID: 84866603608     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01279.x     Document Type: Article

References (39)

1. Adamson J, Beswick A, Ebrahim S. Is stroke the most common cause of disability? J Stroke Cerebrovasc Dis 2004; 13: 171-177.
2. Morancho A, Rosell A, Garcia-Bonilla L, Montaner J. Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Ann N Y Acad Sci 2010; 1207: 123-133.
3. Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 1997; 238: 53-56.
4. Anthony DC, Ferguson B, Matyzak MK, Miller KM, Esiri MM, Perry VH. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 1997; 23: 406-415.
5. Montaner J, varez-Sabin J, Molina CA etal. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 2001; 32: 2762-2767.
6. Rosell A, varez-Sabin J, Arenillas JF etal. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Stroke 2005; 36: 1415-1420.
7. Rosell A, Ortega-Aznar A, varez-Sabin J etal. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 2006; 37: 1399-1406.
8. Luo D, Mari B, Stoll I, Anglard P. Alternative splicing and promoter usage generates an intracellular stromelysin 3 isoform directly translated as an active matrix metalloproteinase. J Biol Chem 2002; 277: 25527-25536.
9. Kwan JA, Schulze CJ, Wang W etal. Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J 2004; 18: 690-692.
10. Si-Tayeb K, Monvoisin A, Mazzocco C etal. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 2006; 169: 1390-1401.
11. Cuadrado E, Rosell A, Borrell-Pages M etal. Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia. J Cereb Blood Flow Metab 2009; 29: 398-410.
12. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007; 27: 697-709.
13. Sbai O, Ould-Yahoui A, Ferhat L etal. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes. Glia 2010; 58: 344-366.
14. Yang Y, Candelario-Jalil E, Thompson JF etal. Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia. J Neurochem 2010; 112: 134-149.
15. Pirici D, Mogoanta L, Kumar-Singh S etal. Antibody elution method for multiple immunohistochemistry on primary antibodies raised in the same species and of the same subtype. J Histochem Cytochem 2009; 2009: 567-575.
16. Schmued LC, Albertson C, Slikker W Jr. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 1997; 751: 37-46.
17. Pirici D, Vandenberghe R, Rademakers R etal. Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family. J Neuropathol Exp Neurol 2006; 65: 289-301.
18. Haltia M, Somer M. Infantile cerebello-optic atrophy. Neuropathology of the progressive encephalopathy syndrome with edema, hypsarrhythmia and optic atrophy (the PEHO syndrome). Acta Neuropathol (Berl) 1993; 85: 241-247.
19. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000; 20: 1681-1689.
20. Tang J, Liu J, Zhou C etal. Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice. J Cereb Blood Flow Metab 2004; 24: 1133-1145.
21. Zhao BQ, Wang S, Kim HY etal. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 2006; 12: 441-445.
22. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998; 21: 75-80.
23. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002; 39: 279-291.
24. Zhao BQ, Tejima E, Lo EH. Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 2007; 38: 748-752.
25. Gasche Y, Fujimura M, Morita-Fujimura Y etal. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 1999; 19: 1020-1028.
26. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998; 29: 1020-1030.
27. Castellanos M, Leira R, Serena J etal. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003; 34: 40-46.
28. Wang X, Jung J, Asahi M etal. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 2000; 20: 7037-7042.
29. Van LP, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007; 82: 1375-1381.
30. Golubkov VS, Boyd S, Savinov AY etal. Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability. J Biol Chem 2005; 280: 25079-25086.
31. Lee ER, Lamplugh L, Kluczyk B, Mort JS, Leblond CP. Protease analysis by neoepitope approach reveals the activation of MMP-9 is achieved proteolytically in a test tissue cartilage model involved in bone formation. J Histochem Cytochem 2006; 54: 965-980.
32. Unal-Cevik I, Kilinc M, Gursoy-Ozdemir Y, Gurer G, Dalkara T. Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cautionary note. Brain Res 2004; 1015: 169-174.
33. Gill SK, Ishak M, Rylett RJ. Exposure of nuclear antigens in formalin-fixed, paraffin-embedded necropsy human spinal cord tissue: detection of NeuN. J Neurosci Methods 2005; 148: 26-35.
34. Colombo JA, Puissant VI. Fluoro Jade stains early and reactive astroglia in the primate cerebral cortex. J Histochem Cytochem 2002; 50: 1135-1137.
35. Cuadrado E, Rosell A, Penalba A etal. Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res 2009; 8: 3191-3197.
36. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J Neurosci 1996; 16: 7910-7919.
37. Copin JC, Goodyear MC, Gidday JM etal. Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice. Eur J Neurosci 2005; 22: 1597-1608.
38. Gu Z, Cui J, Brown S etal. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 2005; 25: 6401-6408.
39. Michaluk P, Kaczmarek L. Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction. Cell Death Differ 2007; 14: 1255-1258.